Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs function by mimicking the inherent actions of GLP-1, a hormone secreted by the https://finnianbxbo996711.wikirecognition.com/user